|
285 IMAGES AT $250.00 EACH FIRM FIXED PRICE
|
261201600005I
|
$277,650
|
|
UNKNOWN, UNKNOWN
|
INTERNAT'L INSTITUTE/MOLECULAR ONCOLOGY
|
|
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/
|
261201500038I
|
$1,236,052
|
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
402 -- TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF BREAST CANCER . CONTRACTOR: MD ANDERSON CANCER CENTER, DUNS: 800772139. CONTRACT NO: HHSN26120150008I, TASK ORDER HHSN26100006. FROM 9/15/17 T
|
261201500018I
|
$1,964,187
|
|
UNKNOWN, UNKNOWN
|
UT MD ANDERSON CANCER CTR
|
|
A 3D Canine Phantom for Applications in Skeletal Molecular Radiotherapy
|
5F31CA130165-04
|
$31,577
|
$31,577
|
Padilla, Laura
|
UNIVERSITY OF FLORIDA
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$151,467
|
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
|
5R01CA200718-02
|
$599,514
|
|
EGGLY, SUSAN
|
WAYNE STATE UNIVERSITY
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
5R01CA190776-03
|
$636,729
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-05
|
$1
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
|
5R01CA200919-02
|
$383,156
|
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
A novel IL-2 biologic and tumor immunity
|
5R21CA195334-02
|
$200,318
|
|
MALEK, THOMAS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
|
5R01CA191489-03
|
$380,278
|
|
NGUYEN, DON
|
YALE UNIVERSITY
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
5R00CA183914-04
|
$254,171
|
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$524,680
|
|
Merlino, Glenn
|
CCR (NCI)
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
5R01CA196266-02
|
$502,591
|
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER
|
261201200034I
|
$2,037,388
|
|
UNKNOWN, UNKNOWN
|
UT MD ANDERSON CANCER CTR
|
|
A PHASE I SINGLE-ARM, MULTICENTER PILOT STUDY AIMED AT VALIDATING Y-OHPDG AS A BIOMARKER AND TESTING THE EFFECTS OF POLYPHENON E ON ITS LEVELS IN PATIENTS WITH CIRRHOSIS
|
261201200035I
|
$2,834,664
|
|
UNKNOWN, UNKNOWN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
|
5R01CA200551-02
|
$247,249
|
|
PARK, SEAN
|
MAYO CLINIC ROCHESTER
|
|
A PILOT STUDY OF MUC1 VACCINE IN CURRENT AND FORMER SMOKERS AT HIGH RISK FOR LUNG CANCER. (MAY2016-08-01)
|
261201200042I
|
$1,711,912
|
|
UNKNOWN, UNKNOWN
|
MAYO CLINIC ROCHESTER
|
|
A prospective, multi-center pivotal study of the LUM Imaging System for real-time, in vivo margin assessment in breast conserving surgery
|
1R01CA212138-01
|
$723,579
|
|
SMITH, BARBARA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A Self-Regulation Approach to an Indoor Tanning Intervention for Frequent Users
|
5K07CA175115-04
|
$137,183
|
|
STAPLETON, JEROD
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER SBIR PHASE I TOPIC 360 POP: 9/19/17 6/18/18
|
261201700051C
|
$300,000
|
|
UNKNOWN, UNKNOWN
|
DIAGNOLOGIX, LLC
|
|
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
|
5R01CA176579-04
|
$289,944
|
|
GUILLEMIN, KAREN
|
UNIVERSITY OF OREGON
|
|
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
|
5R01CA166171-05
|
$480,667
|
|
ZHOU, JINYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$256,560
|
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$380,330
|
|
Aplan, Peter
|
CCR (NCI)
|
|
Adolescent tanning and social media
|
5R03CA201953-02
|
$46,473
|
|
MORENO, MEGAN
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-08
|
$1,998,892
|
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention
|
5K05CA175147-04
|
$88,959
|
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AMPK and AMPK-related kinases in lung cancer development and treatment
|
5R01CA172229-05
|
$402,550
|
|
SHAW, REUBEN
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
An automated high-throughput tissue model for screening metastatic effectors
|
5R01CA186134-03
|
$625,580
|
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
An epigenetic link from CXCL12-CXCR4 axis through nuclear LASP-1 in breast cancer
|
5R21CA202176-03
|
$164,756
|
|
RAMAN, DAYANIDHI
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
|
An integrated approach to dissect the functional network of large non-coding RNA
|
5R00CA175290-05
|
$221,939
|
|
CHEN, YIWEN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
An Interactive Preventive Health Record to Increase Colorectal Cancer Screening
|
5R01CA166375-05
|
$447,403
|
|
JONES, RESA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Anakinra for neutrophilic pustular skin disease
|
ZIA BC 011550
|
$151,876
|
|
Cowen, Edward
|
CCR (NCI)
|
|
Analysis of risk factors for breast cancers classified according to expression of
|
ZIA CP005803-10015
|
$200,414
|
|
Yang, Rose
|
DCEG (NCI)
|
|
Androgen Signaling in prostate cancer progression and CRPC development
|
5R01CA070297-19
|
$1
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Angiogenesis and Tumor Growth
|
ZIA SC 010355
|
$571,072
|
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Antibody therapeutics against biodefense-related diseases
|
ZIA BC 011156
|
$220,413
|
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Antibody-Targeted Cancer Immunotherapy
|
5R01CA050633-27
|
$347,136
|
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Anticarcinogenic Effect of ITCs Against Prostate Cancer
|
5R01CA101753-13
|
$346,500
|
|
SINGH, SHIVENDRA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,944,136
|
$147,207
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Antiviral Mechanism of IFITM Proteins during HIV and Other Retrovirus Infections
|
ZIA BC 011779
|
$206,630
|
|
Compton, Alex
|
CCR (NCI)
|
|
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
|
1R01CA211711-01
|
$388,615
|
|
DRULEY, TODD
|
WASHINGTON UNIVERSITY
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-03
|
$312,244
|
|
KOLB, EDWARD
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Astatine And Iodine Radiolabeled Monoclonal Antibodies
|
5R01CA042324-30
|
$455,654
|
|
ZALUTSKY, MICHAEL
|
DUKE UNIVERSITY
|
|
Auger Electron Radiotherapy of Late-Stage, Castration-Resistant Prostate Cancer using a Brominated Dihydrotestosterone Analogue
|
5R21CA191913-02
|
$229,550
|
|
VEACH, DARREN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Autophagy in Adhesion and Metastasis
|
5R01CA126792-08
|
$317,000
|
|
DEBNATH, JAYANTA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Averting recurrent and resistant ovarian tumors
|
1R01CA211175-01
|
$454,502
|
|
WANG, QIEN
|
OHIO STATE UNIVERSITY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
|
Custer, Mary
|
CCR (NCI)
|
|
Behavioral Science Core
|
ZIC BC 011288
|
$375,769
|
$112,731
|
Wayne, Alan
|
CCR (NCI)
|
Total relevant funding to Sarcoma, Bone (Sarcoma Subset) for this search: $15,320,801
|